Epilepsy, Drug Resistant
13
3
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (13)
Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
Subiculum Electrical Stimulation for Temporal Lobe Epilepsy With Biliteral Hippocampus Sclerosis(SESTB)
Piriform Cortex Electrical Stimulation for Temporal Lobe Epilepsy With Biliteral Hippocampus Sclerosis
Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy
Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)
Propranolol Adjuvant Treatment of Focal Refractory Epilepsy (PATFRE)
Extreme Capsule Electrical Stimulation for Drug-resistant Focal Epilepsy
Enhancing Epilepsy Management With Precision Deep Brain Stimulation
Deep Brain Stimulation Post Failed Vagal Nerve Stimulation
Effectiveness and Safety of Thread Embedding Acupuncture for Drug Resistant Epilepsy
Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy
Drug Resistant Epilepsy: Clinical and Genetic Study
Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy